首页 › 期刊 › Molecular Therapy Oncology
Molecular Therapy Oncology
出版商：Elsevier · ISSN：2950-3299 · 国家/地区：US · 类型：journal · OA 开放获取
核心指标
- 影响因子:8.500
- JCR 分区:Q1
- h-index:14
常见问题
《Molecular Therapy Oncology》的影响因子是多少?
《Molecular Therapy Oncology》的最新影响因子(IF)为 8.500。
《Molecular Therapy Oncology》是几区期刊?
《Molecular Therapy Oncology》JCR 分区为 Q1。
《Molecular Therapy Oncology》是开放获取(OA)期刊吗?
是,《Molecular Therapy Oncology》是开放获取(Open Access)期刊。
本刊近期代表论文
- Chimeric antigen receptor T cell targeting CD44E variant in HCC holds therapeutic potential (2026)
- The multilayered control of acetylation during adenovirus-based immunotherapy of cancer (2025 · 被引 1)
- Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma (2024 · 被引 37)
- Solid cancer-directed CAR T cell therapy that attacks both tumor and immunosuppressive cells via targeting PD-L1 (2024 · 被引 14)
- Dynamic changes of the immune microenvironment in the development of gastric cancer caused by inflammation (2024 · 被引 10)